Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Inflammation
100%
Myocardial Infarction
100%
Scar
100%
Left Ventricular End-diastolic Volume (LVEDV)
16%
Fibrosis
16%
Beneficial Effects
8%
C57BL
8%
Left Ventricular Remodeling
8%
Cardiac Function
8%
Receptor Expression
8%
Interleukin-6
8%
Left Ventricular Hypertrophy
8%
Left Ventricular Function
8%
Interleukin-1β
8%
Adenosine Receptors
8%
Cardiomyocytes
8%
Ligation
8%
Infarcted
8%
Sham Operation
8%
Activation Patterns
8%
Compensatory Hypertrophy
8%
Reduced Activation
8%
Heart Weight
8%
Systolic Function
8%
Early Start
8%
Free Phase
8%
Volume Function
8%
Cardiac Remodeling
8%
Collagen Content
8%
Matrix metalloproteinase-9 (MMP-9)
8%
Inflammatory Fibrosis
8%
Exercise Effect
8%
Left Ventricular Systolic Function
8%
Left Anterior Descending Artery
8%
Continuous Aerobic Training
8%
Medicine and Dentistry
Inflammation
100%
Myocardial Infarction
100%
Fibrosis
25%
End-Diastolic Volume
16%
Heart Ventricle Remodeling
16%
Receptor Expression
8%
Tumor Necrosis Factor
8%
Left Ventricular Hypertrophy
8%
Heart Left Ventricle Function
8%
Interleukin 1
8%
Left Anterior Descending Coronary Artery
8%
Ligation
8%
Heart Function
8%
Gelatinase B
8%
Systolic Function
8%
Mitogen-Activated Protein Kinase
8%
Exercise
8%
Cardiac Muscle Cell
8%
Adenosine Receptor
8%
Sham Procedure
8%
Interleukin 6
8%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Heart Infarction
100%
Fibrosis
25%
Heart Ventricle Remodeling
16%
Tumor Necrosis Factor
8%
Adenosine Receptor
8%
Interleukin 1
8%
Interleukin 6
8%
Heart Left Ventricle Hypertrophy
8%
Gelatinase B
8%
C57BL/6N Mouse
8%